The human placental anti-aggregating factor is neither prostacyclin, nor a prostacyclin metabolite

This publication has 23 references indexed in Scilit:

• In vitro production of prostaglandins E, F, and 6-KETO prostaglandin F1α by human pregnant uterus, decidua and amnion
  Prostaglandins and Medicine, 1981
• Platelet-Activating Factor (PAF-Acether) Secretion from Platelets: Effect of Aggregating Agents
  British Journal of Haematology, 1980
• Bioconversion of arachidonic acid to prostaglandins and related compounds in human amnion
  Biochemical Medicine, 1980
• Inhibitors of platelet aggregation in the fetoplacental unit and myometrium with particular reference to the ADP-degrading property of placenta
  Placenta, 1980
• 6-keto-prostaglandin E1 inhibits the aggregation of human platelets
  European Journal of Pharmacology, 1979
• Synthesis and characterization of prostacyclin, 6-ketoprostaglandin F1.alpha., prostaglandin I1, and prostaglandin I3
  Journal of the American Chemical Society, 1978
• Inhibition of platelet aggregation by a placental substance with prostacyclin-like activity
  Nature, 1977
• Purification and partial characterization of an NADH-linked Δ13-15-ketoprostaglandin reductase from human placenta
  Biochemical and Biophysical Research Communications, 1975
• Purification of the human placental 15 hydroxy prostaglandin dehydrogenase: Properties of the purified enzyme
  FEBS Letters, 1974
• F PROSTAGLANDINS IN AMNIOTIC FLUID DURING PREGNANCY AND LABOUR
  BJOG: An International Journal of Obstetrics and Gynaecology, 1974